Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > CLARIFICATION NEEDED FROM CO.

<< Previous

Bullboard Posts

Next >>

Post by Tarbabyon Aug 21, 2024 5:10pm

226 Views

Post# 36190740

CLARIFICATION NEEDED FROM CO.

By stating that Metformin can potentially activate Rutherrin in a patient with cancer to destroy that cancer even as an outpatient does that not imply that Rutherrin is safe as a medicine given to a human along with Metformin..?? I read it that way.
This should be the BIGGEST NEWS in the entire cancer field and the stock should be soaring..whats wrong here..?

<< Previous

Bullboard Posts

Next >>

Osisko Development receives permits for Cariboo Gold Project